BioInnovation Institute Lands €7M to Accelerate AI Commercialisation

The big picture: The Danish Industry Foundation is investing €7 million in the AI Lab, a new platform run by the BioInnovation Institute (BII), a deep-tech accelerator in Copenhagen, to accelerate AI commercialisation in Denmark.

Why it matters:

• Digital advancement vs. adoption: Despite being one of Europe’s most digitally advanced nations with strong public data systems and research, Danish companies lag in commercializing and adopting AI in industry.
• AI as infrastructure: AI is evolving from a mere tool to a foundational infrastructure, making its effective integration critical for national competitiveness and shaping how companies operate and compete globally.
• Bridging the gap: The AI Lab aims to foster collaboration across academia, startups, and industry, creating a platform to develop AI ideas into solutions with tangible value for businesses and society.

How it works:

• Proven accelerator model: BII, with support from the Novo Nordisk Foundation, has a track record of helping over 140 startups since 2018; this proven approach will now be applied to AI.
• Non-dilutive funding and resources: Selected startups receive non-dilutive funding, retaining full ownership, along with access to unique Danish datasets, computing power, expert networks, and direct links to paying customers for pilot projects.
• Tailored for investment: The program is customized for each participant, focusing on technical uniqueness, commercial potential, and alignment with Danish industry priorities, with the primary goal of preparing them for future investment.

The catch: While Denmark possesses strong digital foundations, the challenge lies in effectively translating research and early adoption into widespread industrial AI commercialization. The AI Lab faces the task of overcoming entrenched corporate inertia and fostering a culture of rapid AI integration to compete with more agile global AI ecosystems.